Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.
España-Cueto S, Loste C, Lladós G, López C, Santos JR, Dulsat G, García A, Carmezim J, Carabia J, Ancochea Á, Fernández-Prendres C, Morales-Indiano C, Quirant B, Martínez-Cáceres E, Sanchez A, Parraga IG, Chamorro A, San José A, Abad E, Muñoz-Moreno JA, Prats A, Fumaz CR, Coll-Fernández R, Estany C, Torrano P, Puig J, Clotet B, Tebé C, Massanella M, Paredes R, Mateu L.
España-Cueto S, et al. Among authors: massanella m.
Nat Commun. 2025 Feb 24;16(1):1929. doi: 10.1038/s41467-025-57198-7.
Nat Commun. 2025.
PMID: 39994269
Free PMC article.
Clinical Trial.